Printer Friendly

CELOX ANNOUNCES MARKETING AGREEMENT

 CELOX ANNOUNCES MARKETING AGREEMENT
 HOPKINS, Minn., May 19 /PRNewswire/ -- Celox Corporation


(NASDAQ: CELX) of Hopkins, a manufacturer and marketer of proprietary innovative serum-free cell biology products, announced that it has signed a marketing agreement with TechGen International, a French company, that has 28 direct sales representatives covering the United Kingdom, France, Germany, Italy, Holland and Belgium.
 As part of Celox's marketing program, having an inroad to the European market could prove to be an important affiliation. The European market is an important user of serum-based media for cell culture and because most all European serum must be imported, it provides an excellent market opportunity for Celox's high-quality, serum-free, cost-effective, defined-basal media products.
 Celox's cell biology products improve the growth, productivity and quality of cell-derived medical and biological products, such as vaccines, monoclonal antibodies, interferons and human growth factors.
 The company's common stock is traded on NASDAQ under the symbol CELX.
 -0- 5/19/92
 /CONTACT: Milo R. Polovina of Celox, 612-933-2616, or George Fredericks of Financial Communication Specialist, 612-337-5880, for Celox/
 (CELX) CO: Celox Corporation ST: Minnesota IN: MTC SU:


AL -- MN004 -- 1766 05/19/92 11:31 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 19, 1992
Words:189
Previous Article:MOODY'S ASSIGNS AN A1 RATING TO CLARK COUNTY, NEVADA GENERAL OBLIGATION (LIMITED TAX) TRANSPORTATION IMPROVEMENT BONDS DATED JUNE 1, 1992
Next Article:AT&T BEGINS DIRECT-DIAL SERVICE TO COMMONWEALTH OF INDEPENDENT STATES
Topics:


Related Articles
CELOX CORPORATION ANNOUNCES APPOINTMENT
CELOX CORPORATION FILES TRADEMARK SUIT AGAINST FORMER ENDOTRONICS
CELOX CORPORATION BOARD AUTHORIZES STOCK REPURCHASE
CELOX CORPORATION HIRES SALES MANAGER
CELOX CORPORATION NAMES SALES AND MARKETING VICE PRESIDENT
CELOX CORPORATION AND AMERICAN TYPE CULTURE COLLECTION TO OFFER SERUM FREE CELL LINES
CELOX LABORATORIES, INC. SIGNS DISTRIBUTION AGREEMENT WITH ICN PHARMACEUTICALS, INC.
CELOX LABORATORIES, INC. COLLABORATES WITH WALTER REED ARMY HOSPITAL
CELOX LABORATORIES, INC. ANNOUNCES RECEIPT OF OFFICE ACTION FROM U.S. PATENT AND TRADEMARK OFFICE
Celox Laboratories, Inc. and TaKaRa Biomedical Enter Into Distribution Agreement

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters